Neuroprotection and underlying mechanisms of oxymatrine in cerebral ischemia of rats

Neurological Research

Volumn 33, Issue 3, 2011, Pages 319-324

  Cui, Lili ^a   Zhang, Xiangjian ^a   Yang, Rui ^a   Wang, Lina ^a   Liu, Lingling ^a   Li, Min ^a   Du, Wei ^a  

^a HEBEI MEDICAL UNIVERSITY   (China)

Author keywords

Cerebral ischemia; Lipoxygenase; Neuroprotection; Oxymatrine

Indexed keywords

ARACHIDONATE 12 LIPOXYGENASE; ARACHIDONATE 15 LIPOXYGENASE; CYTOSOLIC PHOSPHOLIPASE A2; MITOGEN ACTIVATED PROTEIN KINASE P38; OXYMATRINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN INFARCTION SIZE; BRAIN ISCHEMIA; BRAIN WATER; CONTROLLED STUDY; ENZYME PHOSPHORYLATION; MALE; NEUROPROTECTION; NONHUMAN; PROTEIN EXPRESSION; RAT;

ALKALOIDS; ANALYSIS OF VARIANCE; ANIMALS; ARACHIDONATE 15-LIPOXYGENASE; BRAIN EDEMA; BRAIN INFARCTION; DISEASE MODELS, ANIMAL; GENE EXPRESSION REGULATION, ENZYMOLOGIC; INFARCTION, MIDDLE CEREBRAL ARTERY; MALE; NEUROPROTECTIVE AGENTS; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHOLIPASES A2, CYTOSOLIC; QUINOLIZINES; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER;

EID: 79955093970     PISSN: 01616412     EISSN: None     Source Type: Journal    
DOI: 10.1179/016164110X12759951866876     Document Type: Article

References (26)

1. Vikman P, Ansar S, Henriksson M, Stenman E, Edvinsson L. Cerebral ischemia induces transcription of inflammatory and extracellular-matrix-related genes in rat cerebral arteries. Exp Brain Res 2007;183:499-510.
2. Baskaya MK, Prasad MR, Donaldson D, Hu Y, Rao AM, Dempsey RJ. Enhanced accumulation of free fatty acids in experimental focal cerebral ischemia. Prostaglandins Leukot Essent Fatty Acids 1996;54:167-71.
3. Muralikrishna Adibhatla R, Hatcher JF. Phospholipase A2, reactive oxygen species, and lipid peroxidation in cerebral ischemia. Free Radic Biol Med 2006;40:376-87.
4. Farias SE, Basselin M, Chang L, Heidenreich KA, Rapoport SI, Murphy RC. Formation of eicosanoids, E2/D2 isoprostanes, and docosanoids following decapitation-induced ischemia, measured in high-energy-microwaved rat brain. J Lipid Res 2008;49:1990-2000.
5. Fan H, Li L, Zhang X, Liu Y, Yang C, Yang Y, et al. Oxymatrine downregulates TLR4, TLR2, MyD88, and NFkappaB and protects rat brains against focal ischemia. Mediators Inflamm 2009;2009:704706.
6. Yang C, Zhang X, Fan H, Liu Y. Curcumin upregulates transcription factor Nrf2, HO-1 expression and protects rat brains against focal ischemia. Brain Res 2009;1282:133-41.
7. Nito C, Kamada H, Endo H, Niizuma K, Myer DJ, Chan PH. Role of the p38 mitogen-activated protein kinase/cytosolic phospholipase A2 signaling pathway in blood-brain barrier disruption after focal cerebral ischemia and reperfusion. J Cereb Blood Flow Metab 2008;28:1686-96.
8. Adibhatla RM, Hatcher JF. Citicoline decreases phospholipase A2 stimulation and hydroxyl radical generation in transient cerebral ischemia. J Neurosci Res 2003;73:308-15.
9. van Leyen K, Kim HY, Lee SR, Jin G, Arai K, Lo EH. Baicalein and 12/15-lipoxygenase in the ischemic brain. Stroke 2006;37:3014-8.
10. Bonventre JV, Huang Z, Taheri MR, O'Leary E, Li E, Moskowitz MA, et al. Reduced fertility and postischaemic brain injury in mice deficient in cytosolic phospholipase A2. Nature 1997;390:622-5.
11. Tabuchi S, Uozumi N, Ishii S, Shimizu Y, Watanabe T, Shimizu T. Mice deficient in cytosolic phospholipase A2 are less susceptible to cerebral ischemia/reperfusion injury. Acta Neurochir Suppl 2003;86:169-72.
12. Xiang X, Wang G, Cai X, Li Y. Effect of oxymatrine on murine fulminant hepatitis and hepatocyte apoptosis. Chin Med J (Engl) 2002;115:593-6.
13. Ma SC, Du J, But PP, Deng XL, Zhang YW, Ooi VE, et al. Antiviral Chinese medicinal herbs against respiratory syncytial virus. J Ethnopharmacol 2002;79:205-11.
14. Xu GL, Yao L, Rao SY, Gong ZN, Zhang SQ, Yu SQ. Attenuation of acute lung injury in mice by oxymatrine is associated with inhibition of phosphorylated p38 mitogenactivated protein kinase. J Ethnopharmacol 2005;98:177-83.
15. Sun HL, Li L, Shang L, Zhao D, Dong DL, Qiao GF, et al. Cardioprotective effects and underlying mechanisms of oxymatrine against Ischemic myocardial injuries of rats. Phytother Res 2008;22:985-9.
16. Jiang H, Meng F, Li J, Sun X. Anti-apoptosis effects of oxymatrine protect the liver from warm ischemia reperfusion injury in rats. World J Surg 2005;29:1397-401.
17. Liu Y, Zhang XJ, Yang CH, Fan HG. Oxymatrine protects rat brains against permanent focal ischemia and downregulates NF-kappaB expression. Brain Res 2009;1268:174-80.
18. Longa EZ, Weinstein PR, Carlson S, Cummins R. Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke 1989;20:84-91.
19. Cui L, Zhang L, Yang L, Wang L, Liu L, Li M, et al. Neuroprotection of early and short-time applying atorvastatin in the acute phase of cerebral ischemia: down-regulated 12/15- LOX, p38MAPK and cPLA2 expression, ameliorated BBB permeability. Brain Res 2010;1325:164-73.
20. Donnan GA, Fisher M, Macleod M, David SM. Stroke. Lancet 2008;371:1612-23.
21. Lakhan SE, Kirchgessner A, Hofer M. Inflammatory mechanisms in ischemic stroke: therapeutic approaches. J Transl Med 2009;7:97.
22. Fassbender K, Rossol S, Kammer T, Daffertshofer M, Wirth S, Hennerici M. Proinflammatory cytokines in serum of patients with acute cerebral ischemia: kinetics of secretion and relation to the extent of brain damage and outcome of disease. J Neurol Sci 1994;122:135-9.
23. Koga H, Austin G. Cortical oxidative metabolism under conditions of ischemia, hypoxia, and asphyxia in the rabbit. J Neurosurg 1983;59:57-62.
24. Tuttolomondo A, di Sciacca R, di Raimondo D, Renda C, Pinto A, Licata G. Inflammation as a therapeutic target in acute ischemic stroke treatment. Curr Top Med Chem 2009;9:1240-60.
25. Zhao J, Yu S, Tong L, Zhang F, Jiang X, Pan S, et al. Oxymatrine attenuates intestinal ischemia/reperfusion injury in rats. Surg Today 2008;38:931-7.
26. Dong Y, Xi H, Yu Y, Wang Q, Jiang K, Li L. Effects of oxymatrine on the serum levels of T helper cell 1 and 2 cytokines and the expression of the S gene in hepatitis B virus S gene transgenic mice: a study on the anti-hepatitis B virus mechanism of oxymatrine. J Gastroenterol Hepatol 2002;17:1299-306.